SANDIMMUN conc perf 250 mg/5ml 10 amp 5 ml
7680449150141
CH-44915
L04AD01
07.15.0.
Reimbursement limitations:
SANDIMMUN
Transplantations.
Maladies immunologiques graves ainsi que rares (aussi celles enregistrées sous Possibilité d'emploi), ne répondant …
1 / 2
google
Details
- Product number
- 4491501
- CPT
- -
- Packaging group
- 10 x 5
- Unit
- ml
- Composition
- ciclosporinum 50 mg, macrogol 36 glyceroli ricinioleas 650 mg, ethanolum 261 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Sandimmun, Infusionskonzentrat
Infusionskonzentrat
10 x 5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
650.0 MG | Substance | HPADK |
|
(N/A)
|
261.0 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 157.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 44915
- Drug name
- Sandimmun, Infusionskonzentrat
- Galenic form
- KOPA
- ATC Code
- L04AD01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/12/1982
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SANDIMMUN conc perf 250 mg/5ml 10 amp 5 ml
- Description (DE)
- SANDIMMUN Inf Konz 250 mg/5ml 10 Amp 5 ml
- Market launch
- 28/12/1982
- Narcotic (BTM)
- No